ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiology"

  • Abstract Number: 1865 • ACR Convergence 2021

    Incidence, Prevalence, and Mortality of Chronic Periaortitis: A Population-based Study

    Umar Ghaffar1, Kenneth Warrington2, Stephanie Duong1, Cynthia Crowson3, Michelle Burke1, Boyd Viers1, Aaron Potretzke1, Haraldur Bjarnason1 and Matthew Koster1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, Minnesota, 3Mayo Clinic, Eyota, MN

    Background/Purpose: Chronic periaortitis is an inflammatory condition that typically involves the infrarenal portion of the abdominal aorta. To date, no epidemiologic studies have been performed…
  • Abstract Number: 0295 • ACR Convergence 2021

    Weight History and Associations with Cardiovascular Risk in Patients with Rheumatoid Arthritis

    Lydia Federico1, Kaleb Michaud2, Kristin Wipfler3, Gulsen Ozen4 and Joshua Baker1, 1University of Pennsylvania, Philadelphia, PA, 2University of Nebraska Medical Center, Omaha, NE, 3FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 4University of Nebraska Medical Center, Bellevue, NE

    Background/Purpose: Cardiovascular disease (CVD) is the leading cause of mortality in rheumatoid arthritis (RA), but traditional CVD risk factors may not accurately characterize risk. For…
  • Abstract Number: 0563 • ACR Convergence 2021

    Validating the FRAX Score in a US Population-Based Study of Patients with Rheumatoid Arthritis

    Madeline Peterson1, Cynthia Crowson2, Elena Myasoedova1, Shreyasee Amin1, John Davis1, Sara Achenbach1, Sundeep Kholsa1 and Elizabeth Atkinson1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Eyota, MN

    Background/Purpose: The FRAX tool, launched by the World Health Organization Collaborating Centre at the University of Sheffield in 2008 (https://www.sheffield.ac.uk/FRAX/), is widely used to quickly…
  • Abstract Number: 0617 • ACR Convergence 2021

    Concerns and Beliefs About COVID-19 Vaccination Among Racial and Ethnic Minority Patients with Rheumatic Disease

    Maria I. Danila, Lesley Jackson, Amy Mudano, Giovanna Rosas, Jeanne Merchant, Jeffrey Foster and Kenneth Saag, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Alabama lags behind many other states in COVID-19 vaccination uptake and racial/ethnic minority groups face COVID-19 vaccine access disparities. Moreover, lack of vaccination access…
  • Abstract Number: 1023 • ACR Convergence 2021

    Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network

    William Nowell1, Edward L. Barnes2, Nupur Parikh1, Shilpa Venkatachalam1, Michael Kappelman2, Jeffrey Curtis3, Peter Merkel4, Dianne Shaw5, Kalen Young5 and Michael George4, 1Global Healthy Living Foundation, Upper Nyack, NY, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 4University of Pennsylvania, Philadelphia, PA, 5Vasculitis Foundation, Kansas City, MO

    Background/Purpose: Ensuring adequate representation of racial/ethnic minorities in research necessitates understanding the prevalence of rheumatic and musculoskeletal diseases in these populations. We sought to evaluate…
  • Abstract Number: 1326 • ACR Convergence 2021

    Epidemiology of Comorbidities in an Incident Psoriasis Cohort: A Population-Based Study

    Paras Karmacharya1, Rikesh Chakradhar2, Alexis Ogdie3, John Davis2, Kerry Wright2, Megha M. Tollefson2, Ali Duarte-Garcia2, Delamo Bekele2, Hilal Maradit Kremers2, Floranne Ernste2, Tina Gunderson2, Cassondra Hulshizer2 and Cynthia Crowson4, 1Mayo Clinic, Rochester MN; Vanderbilt University, Nashville, TN, 2Mayo Clinic, Rochester, MN, 3University of Pennsylvania, Philadelphia, PA, 4Mayo Clinic, Eyota, MN

    Background/Purpose: Psoriasis, a chronic immune-mediated skin disease affecting 2-4% of the US population, is increasingly recognized as a systemic inflammatory disorder associated with cardiometabolic and…
  • Abstract Number: 1903 • ACR Convergence 2021

    Does Limited Stair Climbing Lead to Poor Future Health? The Relationship Between Short-term Trajectories of Stair Climbing Frequency and Incident Slow Gait Speed over 1 and 2 Years in Adults with Knee Osteoarthritis

    Jason Jakiela1, Yuqing Zhang2, Dana Voinier1, Thomas Bye1, Jennifer Copson1 and Daniel White1, 1University of Delaware, Newark, DE, 2Massachusetts General Hospital, Quincy, MA

    Background/Purpose: Knee osteoarthritis (OA) is a common cause of functional limitation in older adults, and difficulty with climbing stairs is one of the first limitations…
  • Abstract Number: 0329 • ACR Convergence 2021

    Racial and Ethnic Disparities in Risk of End-Organ Disease Following SLE Diagnosis in a Multi-Ethnic Cohort

    ALFREDO AGUIRRE1, Andrea Seet1, Laura Trupin2, Patricia Katz1, Kamil Barbour3, Cristina Lanata4, Maria Dall'Era5 and Jinoos Yazdany1, 1University of California San Francisco, San Francisco, CA, 2UC San Francisco, San Francisco, CA, 3Centers for Disease Control, Atlanta, GA, 4University of California San Francisco, Moss Beach, CA, 5University of California San Francisco, Corte Madera, CA

    Background/Purpose: Racial and ethnic minorities experience a disproportionate burden of systemic lupus erythematosus (SLE) as well as earlier development of lupus manifestations as compared to…
  • Abstract Number: 0564 • ACR Convergence 2021

    Associations of Sinusitis, Pharyngitis, and Respiratory Tract Disease Burden with Incident Rheumatoid Arthritis

    Vanessa Kronzer1, Weixing Huang2, Alessandra Zaccardelli2, Cynthia Crowson3, John Davis1, Robert Vassallo1, Tracy Doyle4, Elena Losina2 and Jeffrey Sparks2, 1Mayo Clinic, Rochester, MN, 2Brigham and Women's Hospital, Boston, MA, 3Mayo Clinic, Eyota, MN, 4Brigham and Women's Hospital, West Roxbury, MA

    Background/Purpose: Increasing evidence implicates respiratory mucosa in the pathogenesis of rheumatoid arthritis (RA). However, individual respiratory tract diseases, especially of the upper airways, sinuses, and…
  • Abstract Number: 0672 • ACR Convergence 2021

    Does Obesity Affect Gout Risk Differently Among Genetically Predisposed Individuals?: Sex-Specific Prospective Cohort Study Findings over >32 Years

    Chio Yokose1, Natalie McCormick2, Na Lu3, Amit Joshi2 and Hyon K. Choi4, 1Massachusetts General Hospital, Waltham, MA, 2Massachusetts General Hospital, Boston, MA, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Massachusetts General Hospital, Lexington, MA

    Background/Purpose: Two recent analyses of the Global Burden of Disease Study reported on the rising global burden of gout (Safiri A&R 2020, Xia Rheumatology 2020).…
  • Abstract Number: 1027 • ACR Convergence 2021

    Epidemiology of Latent Tuberculosis Infection in Patients with Rheumatic Immune-mediated Diseases: Single University Study of 1117 Patients

    David Martinez-Lopez1, Joy Osorio-Chávez1, Carmen Álvarez-Reguera1, Virginia Portilla2, Miguel Ángel gonzalez-Gay3 and Ricardo Blanco4, 1Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL; Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL, Division of Rheumatology, Hospital Universitario Marqués de Valdecilla; School of Medicine, Universidad de Cantabria, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 4Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Background: Patients with rheumatologic immune-mediated diseases (R-IMID) with Latent tuberculosis infection (LTBI) requiring biologic therapy (BT) are at an increased risk of active tuberculosis…
  • Abstract Number: 1393 • ACR Convergence 2021

    All-cause Mortality in a Hospital Ascertained Cohort with Giant Cell Arteritis: A Longitudinal Population-level Data Linkage Cohort Study

    Helen Keen1, Warren Raymond2, Susan Lester3, David Preen2, Charles Inderjeeth4, Catherine Hill5 and Johannes Nossent2, 1University of Western Australia, Daglish, Australia, 2University of Western Australia, Perth, Australia, 3Rheumatology Department, The Basil Hetzel Institute, The Queen Elizabeth Hospital, Adelaide, Australia, 4University of Western Australia, Nedlands, Perth, Australia, 5Queen Elizabeth Hospital, Woodville, Australia

    Background/Purpose: Giant Cell Arteritis (GCA) is the most common primary vasculitis in high income countries and ischemic complications of GCA include blindness and stroke. The…
  • Abstract Number: 1923 • ACR Convergence 2021

    Has the Incidence of Total Joint Arthroplasty in Rheumatoid Arthritis Decreased in the Era of Biologics Use? A Population-based Incident Cohort Study 1995–2015

    Vivienne Zhou1, Diane Lacaille1, Na Lu2, Jacek Kopec3, Don Garbuz1, Yi Qian4, J. Antonio Avina-Zubieta1, John Esdaile2 and Hui Xie1, 1Arthritis Research Canada, Richmond, BC, Canada, 2Arthritis Research Canada, Vancouver, BC, Canada, 3University of British Columbia, Richmond, BC, Canada, 4University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Total joint arthroplasty (TJA) is an undesirable long-term outcome of rheumatoid arthritis (RA) due to joint damage from uncontrolled inflammation. Although biological disease-modifying anti-rheumatic…
  • Abstract Number: 0086 • ACR Convergence 2021

    SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review

    Richard Conway1, Alyssa Grimshaw2, Maximilian Konig3, Michael Putman4, Ali Duarte-Garcia5, Candice Low6, Shangyi Jin7, Diego Cabrera8, Yu Pei Eugenia Chock9, Berk Degirmenci10, Eimear Duff11, Bugra Egeli12, Elizabeth Graef13, Akash Gupta14, Patricia Harkins15, Bimba Franziska Hoyer16, Aruni Jayatilleke17, Christopher Kasia18, Aneka Khilnani19, Adam Kilian20, Alfred Kim21, Chung Mun Alice Lin22, Laurie Proulx23, Sebastian Sattui24, Namrata Singh25, Jeffrey Sparks26, Herman Tam27, Leslie Yingzhijie Tseng2, Manuel Ugarte-Gil28, Natasha Ung29, Leanna Wise30, Ziyi Yang31, Kristen Young32, Jean Liew33, Rebecca Grainger34, Zachary Wallace35 and Evelyn Hsieh2, 1St. James's University Hospital, Dublin, Ireland, 2Yale School of Medicine, New Haven, CT, 3The Johns Hopkins University School of Medicine, Baltimore, MD, 4Medical College of Wisconsin, Brookfield, WI, 5Mayo Clinic, Rochester, MN, 6St. Vincent's University Hospital, Dublin, Ireland, 7Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China (People's Republic), 8Yale School of Medicine, Lima, Peru, 9Yale School of Medicine, Greenwich, CT, 10St. Elizabeth's Medical Center, Boston, MA, 11St. James's Hospital, Dublin, Ireland, 12Boston Children's Hospital, Boston, MA, 13Emerson Hospital, Concord, MA, 14Department of Medicine, Yale University School of Medicine, New Haven, CT, 15St James hospital, Dublin, Ireland, 16Universittsklinikum Schleswig-Holstein, Kiel, Germany, 17Temple University, Philadelphia, PA, 18The Medical College of Wisconsin, Maywood, IL, 19George Washington University School of Medicine and Health Sciences, Washington, DC, 20George Washington University, Melbourne, FL, 21Washington University School of Medicine, St. Louis, MO, 22Newcastle University, Newcastle, United Kingdom, 23Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, 24Hospital for Special Surgery, New York, NY, 25University of Washington, Bellevue, WA, 26Brigham and Women's Hospital, Boston, MA, 27Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada, 28Hospital Guillermo Almenara Irigoyen, Essalud/Universidad Científica del Sur, Lima, Peru, 29New South Wales Health, Sydney, Australia, 30LAC+USC/Keck Medicine of USC, Pasadena, CA, 31Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing 100730, China, Beijing, China (People's Republic), 32University of Texas Southwestern Medical Center, Dallas, TX, 33Boston University, Boston, MA, 34University of Otago, Wellington, New Zealand, 35Massachusetts General Hospital, Newton, MA

    Background/Purpose: The relative risk of COVID-19 among patients with rheumatic and musculoskeletal disease (RMD) and the comparative severity of COVID-19 infection in RMD remain uncertain.…
  • Abstract Number: 0332 • ACR Convergence 2021

    Prevalence of Systemic Lupus Erythematosus in the United States: Updated Population Representative Estimates from the Medical Expenditure Panel Survey (MEPS) 2016-2018

    Michael Pollack1, Sandra Sze-jung Wu1, Eilleen Farrelly2, Shannon Grabich3 and Robert Ortmann4, 1AstraZeneca, Wilmington, DE, 2Xcenda, Carrollton, TX, 3Xcenda, Durham, NC, 4AstraZeneca, Greenwood, IN

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multi-organ, autoimmune disease whose prevalence in the US has not been recently updated in real-world studies. Prevalence…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 46
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology